Australian global biotech company CSL: An agreement was reached with the US government to lower drug prices and support investment in the US production sector. The agreement aims to reduce the price of CSL therapeutics while implementing CSL's $1.5 billion plan to expand its US production capacity in Illinois. The project is expected to create at least 300 pharmaceutical production jobs, as well as about 800 construction and related jobs. The agreement gave CSL more certainty in US drug pricing and some Section 232 tariffs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.